– Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer. Cancer Res, 2022;82(16):2838–2847.
– Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors. JCO Precision Oncology, 2022;6:e2100372.
– Genomic Profiling for Clinical Decision Making in Lymphoid Neoplasms. Blood. 2022 Aug 24; doi: 10.1182/blood.2022015854.
Filed under Cáncer, Diagnóstico, Genómica by on . Comment.